An in silico Approach to Predict Susceptibility to DILI in Metabolic Syndrome: An Alternative to Animal Experiments
Metabolic disorders, such as type 2 diabetes and atherosclerosis form a cluster of different conditions caused and mediated by complex multi-molecular interactions. The presence of metabolic syndrome (MetS) is reported to predispose an individual to drug-induced liver injury (DILI), from drugs such as acetaminophen, halothane, statin. However, the molecular mechanisms PDF